Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Clinical and Experimental Allergy is Scopus-indexed (Q1, CiteScore 8.9), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Wiley-Blackwell Publishing Ltd.
Checked against the index lists dated .
ISSN 0954-7894Verify ISSN ↗1365-2222Verify ISSN ↗
Publisher: Wiley-Blackwell Publishing Ltd
Cost to publish: About US$4,760 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Immunology and Allergy | 44 / 234 | 81st | Q1 |
| Immunology | 50 / 243 | 79th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1971–present, best quartile Q1, CiteScore 8.9.
Clinical and Experimental Allergy is Q1 in Immunology and Allergy (rank 44 of 234) and Q1 in Immunology (rank 50 of 243), by CiteScore 2025.
Clinical and Experimental Allergy is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 8.9, which places it in quartile Q1 at the 81st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.350, quartile Q2, with an H-index of 182.
The publisher lists an article processing charge of about US$4,760 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Clinical and Experimental Allergy is published by Wiley-Blackwell Publishing Ltd. Its print ISSN is 0954-7894 and its online ISSN is 1365-2222.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Clinical and Experimental Allergy has an h-index of 204 and a 2-year mean of 2.31 citations per paper (OpenAlex). Its Scopus CiteScore is 8.9, quartile Q1. On 2-year citations it ranks #105 of 231 Scopus journals in Immunology and Allergy.
Clinical and Experimental Allergy published 260 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2026), authors are most often from China (15.7%), United Kingdom (13%) and South Korea (7.2%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.